$TLRY
Tilray Brands, Inc. Stock $tlry

$tlry Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000156459022026894 Filed on July 28, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022
Revenue	$153.2M	$153.3M	$628.4M
YoY Change	-8.82%	7.8%	22.47%
Cost Of Revenue	$104.6M	$160.1M	$511.6M
YoY Change	-10.65%	-58.95%	31.2%
Gross Profit	$48.61M	-$6.733M	$116.8M
YoY Change	-4.59%	-129.93%	-5.17%
Gross Profit Margin	31.73%	-4.39%	18.59%
Selling, General & Admin	$50.18M	$62.50M	$197.7M
YoY Change	-11.84%	-59.86%	43.12%
% of Gross Profit	103.22%		169.26%
Research & Development	$166.0K	$54.00K	$1.518M
YoY Change	-78.85%	-93.49%	82.89%
% of Gross Profit	0.34%		1.3%
Depreciation & Amortization	$34.07M	$40.77M	$154.6M
YoY Change	-13.38%	-35.21%	127.9%
% of Gross Profit	70.08%		132.34%
Operating Expenses	$69.79M	$66.61M	$727.2M
YoY Change	-41.59%	-73.91%	184.79%
Operating Profit	-$21.18M	-$73.35M	-$610.4M
YoY Change	-69.1%	-68.5%	361.83%
Interest Expense	-$4.413M	-$3.537M	$39.68M
YoY Change	-56.61%	-98.42%	28.4%
% of Operating Profit
Other Income/Expense, Net	-$32.99M	$9.357M	$197.7M
YoY Change	-167.52%	1.17%	-206.94%
Pretax Income	-$58.58M	-$461.6M	-$440.7M
YoY Change	96.31%	33.8%	27.74%
Income Tax	$7.211M	-$3.803M	-$6.542M
% Of Pretax Income
Net Earnings	-$73.48M	-$478.1M	-$476.8M
YoY Change	76.43%	-1112.92%	29.77%
Net Earnings / Revenue	-47.96%	-311.85%	-75.88%
Basic Earnings Per Share	-$0.13		-$0.90
Diluted Earnings Per Share	-$0.13	-$930.3K	-$0.90
COMMON SHARES
Basic Shares Outstanding	536.4M	497.7M	481.2M
Diluted Shares Outstanding	575.3M		481.2M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$490.6M	$415.9M	$415.9M
YoY Change	30.39%	-14.85%	-14.85%
Cash & Equivalents	$490.6M	$415.9M	$415.9M
Short-Term Investments
Other Short-Term Assets	$77.24M	$46.79M	$46.79M
YoY Change	-34.14%	445.48%	18.18%
Inventory	$244.7M	$245.5M	$245.5M
Prepaid Expenses
Receivables	$98.35M	$95.28M	$95.28M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$910.9M	$803.5M	$803.5M
YoY Change	7.85%	-9.07%	-9.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$553.6M	$587.5M	$600.5M
YoY Change	-10.9%	-9.71%	-10.24%
Goodwill	$2.618B	$2.641B
YoY Change	-6.81%	-6.76%
Intangibles	$1.211B	$1.278B
YoY Change		-20.43%
Long-Term Investments	$4.764M	$15.00M	$15.00M
YoY Change	-97.5%	85.07%	-41.83%
Other Assets	$4.754M	$314.0K	$314.0K
YoY Change	2301.01%	-96.21%	-96.21%
Total Long-Term Assets	$4.682B	$4.646B	$4.646B
YoY Change	-8.95%	-9.64%	-9.64%
TOTAL ASSETS
Total Short-Term Assets	$910.9M	$803.5M	$803.5M
Total Long-Term Assets	$4.682B	$4.646B	$4.646B
Total Assets	$5.592B	$5.450B	$5.450B
YoY Change	-6.58%	-9.55%	-9.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$75.84M	$68.60M	$68.60M
YoY Change	22.34%	18.89%	18.89%
Accrued Expenses	$62.82M	$57.50M	$89.38M
YoY Change	-26.94%	-48.93%	-37.91%
Deferred Revenue
YoY Change
Short-Term Debt	$18.28M	$18.12M	$18.12M
YoY Change	98.65%	107.9%	107.9%
Long-Term Debt Due	$64.10M	$67.82M	$67.82M
YoY Change	107.86%	85.2%	81.96%
Total Short-Term Liabilities	$273.3M	$280.3M	$280.3M
YoY Change	-48.13%	-30.13%	-30.13%
LONG-TERM LIABILITIES
Long-Term Debt	$558.6M	$117.9M	$519.8M
YoY Change	238.71%	-29.62%	-40.29%
Other Long-Term Liabilities	$179.0K	$191.0K	$11.52M
YoY Change	-99.69%	-95.11%	-48.51%
Total Long-Term Liabilities	$179.0K	$118.1M	$531.3M
YoY Change	-99.89%	-31.11%	-40.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$273.3M	$280.3M	$280.3M
Total Long-Term Liabilities	$179.0K	$118.1M	$531.3M
Total Liabilities	$1.029B	$1.008B	$1.051B
YoY Change	-38.25%	-35.37%	-32.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.036B	-$962.9M
YoY Change		98.1%
Common Stock	$5.641B	$5.382B
YoY Change		12.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.525B	$4.399B	$4.399B
YoY Change
Total Liabilities & Shareholders Equity	$5.592B	$5.450B	$5.450B
YoY Change	-6.58%	-9.55%	-9.55%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022
OPERATING ACTIVITIES
Net Income	-$73.48M	-$478.1M	-$476.8M
YoY Change	76.43%	-1112.92%	29.77%
Depreciation, Depletion And Amortization	$34.07M	$40.77M	$154.6M
YoY Change	-13.38%	-35.21%	127.9%
Cash From Operating Activities	-$46.27M	-$20.52M	-$177.3M
YoY Change	-50.37%	-35.27%	296.41%
INVESTING ACTIVITIES
Capital Expenditures	-$3.000M	-$5.594M	-$34.06M
YoY Change	-81.61%	-84.63%	-12.37%
Acquisitions	$0.00		-$326.0K
YoY Change			-99.51%
Other Investing Activities	$1.463M	$679.0K	$12.53M
YoY Change	-80.99%	-99.18%	-85.25%
Cash From Investing Activities	-$1.537M	-$4.915M	-$21.53M
YoY Change	-82.17%	-110.64%	-146.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$262.5M
YoY Change			155.98%
Debt Paid & Issued, Net	$5.196M
YoY Change
Cash From Financing Activities	$123.6M	161.8M	128.2M
YoY Change	-1639.86%	-247.4%	3.13%
NET CHANGE
Cash From Operating Activities	-$46.27M	-20.52M	-177.3M
Cash From Investing Activities	-$1.537M	-4.915M	-21.53M
Cash From Financing Activities	$123.6M	161.8M	128.2M
Net Change In Cash	$74.73M	136.4M	-72.56M
YoY Change	-166.63%	-243.09%	-156.76%
FREE CASH FLOW
Cash From Operating Activities	-$46.27M	-$20.52M	-$177.3M
Capital Expenditures	-$3.000M	-$5.594M	-$34.06M
Free Cash Flow	-$43.27M	-$14.93M	-$143.2M
YoY Change	-43.74%	-417.86%	2350.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021	us-gaap	Operating Expenses OperatingExpenses	255353000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-132171000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-104009000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-19371000
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	156649000
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Registrant Name EntityRegistrantName	TILRAY BRANDS, INC.
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Trading Symbol TradingSymbol	TLRY
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--05-31
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	us-gaap	Gross Profit GrossProfit	116817000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162801000
CY2020	us-gaap	Operating Expenses OperatingExpenses	200062000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27977000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14195000
CY2020	us-gaap	Profit Loss ProfitLoss	-100833000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-27538000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-18001000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587499000
CY2022Q2	us-gaap	Inventory Net InventoryNet	245529000
CY2021Q2	us-gaap	Inventory Net InventoryNet	256429000
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	48920000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	803503000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27944000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-102540000
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001731348
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1518000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	628372000
CY2022	dei	Entity File Number EntityFileNumber	001-38594
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021Q4	dei	Entity Public Float EntityPublicFloat	4700000
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	265 Talbot Street West
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Leamington
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	N8H 5L4
CY2022	dei	City Area Code CityAreaCode	844
CY2022	dei	Local Phone Number LocalPhoneNumber	845-7291
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	536390766
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4310622
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	513085000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511555000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	389903000
CY2021	us-gaap	Gross Profit GrossProfit	123182000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	111575000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15138000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-858000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-650233000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-214596000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13305000
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1277875000
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	us-gaap	Profit Loss ProfitLoss	-336014000
CY2020	us-gaap	Profit Loss ProfitLoss	-100833000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177262000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44717000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-100627000
CY2021Q2	tlry	Working Capital WorkingCapital	482368000
CY2022	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2022	us-gaap	Lessee Operating Lease Existence Of Option To Terminate LesseeOperatingLeaseExistenceOfOptionToTerminate	true
CY2022	us-gaap	Lessee Finance Lease Existence Of Option To Extend LesseeFinanceLeaseExistenceOfOptionToExtend	true
CY2022	us-gaap	Lessee Finance Lease Existence Of Option To Terminate LesseeFinanceLeaseExistenceOfOptionToTerminate	true
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseRightOfUseAsset
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseRightOfUseAsset
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentNet
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-109185000
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2021Q2	tlry	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	53946000
CY2021Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	8717000
CY2022Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	117879000
CY2021Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#Liabilities
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#Liabilities
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#Liabilities
CY2021Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LiabilitiesCurrent
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#Liabilities
CY2022	tlry	Debt Instrument Valuation Techniques Extensible List DebtInstrumentValuationTechniquesExtensibleList	ValuationsTechniqueBlackScholesMember
CY2022	tlry	Warrants And Rights Outstanding Valuations Technique Extensible List WarrantsAndRightsOutstandingValuationsTechniqueExtensibleList	ValuationsTechniqueBlackScholesMember
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Valuation Technique Extensible List BusinessCombinationContingentConsiderationLiabilityValuationTechniqueExtensibleList	http://fasb.org/us-gaap/2022#ValuationTechniqueDiscountedCashFlowMember
CY2022	tlry	Debt Securities Available For Sale Valuation Techniques Extensible List DebtSecuritiesAvailableForSaleValuationTechniquesExtensibleList	ValuationsTechniqueBlackScholesMember
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Auditor Firm AuditorFirmId	271
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	415909000
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	488466000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	95279000
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	87309000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	46786000
CY2021Q2	tlry	Convertible Notes Receivable Current ConvertibleNotesReceivableCurrent	2485000
CY2021Q2	us-gaap	Assets Current AssetsCurrent	883609000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	650698000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12996000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18267000
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1605918000
CY2022Q2	us-gaap	Goodwill Goodwill	2641305000
CY2021Q2	us-gaap	Goodwill Goodwill	2832794000
CY2022Q2	tlry	Interest In Equity Investees InterestInEquityInvestees	4952000
CY2021Q2	tlry	Interest In Equity Investees InterestInEquityInvestees	8106000
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	10050000
CY2021Q2	us-gaap	Long Term Investments LongTermInvestments	17685000
CY2022Q2	tlry	Convertible Notes Receivable Noncurrent ConvertibleNotesReceivableNoncurrent	111200000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	314000
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8285000
CY2022Q2	us-gaap	Assets Assets	5449694000
CY2021Q2	us-gaap	Assets Assets	6025362000
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	18123000
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	157431000
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	212813000
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	16007000
CY2021Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	60657000
CY2022Q2	tlry	Warrant Liability Current WarrantLiabilityCurrent	14255000
CY2021Q2	tlry	Warrant Liability Current WarrantLiabilityCurrent	78168000
CY2022Q2	tlry	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	6703000
CY2021Q2	tlry	Operating And Finance Lease Liability Current OperatingAndFinanceLeaseLiabilityCurrent	4264000
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	67823000
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	36622000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	280342000
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	30934000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	191000
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	17539000
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	401241000
CY2022Q2	tlry	Operating And Finance Lease Liability Noncurrent OperatingAndFinanceLeaseLiabilityNoncurrent	11329000
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	15266000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	830000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1916000
CY2022	tlry	Stock Issued During Period Value Ddh Note StockIssuedDuringPeriodValueDDHNote	-7484000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-44650000
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	167486000
CY2022Q2	tlry	Convertible Debentures Noncurrent ConvertibleDebenturesNoncurrent	401949000
CY2021Q2	tlry	Convertible Debentures Noncurrent ConvertibleDebenturesNoncurrent	667624000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	196638000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	265845000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-344986000
CY2021Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3907000
CY2022Q2	us-gaap	Liabilities Liabilities	1008328000
CY2021Q2	us-gaap	Liabilities Liabilities	1560049000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	990000000
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532674887
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532674887
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	446440641
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	446440641
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	53000
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	46000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	5382367000
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4792406000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20764000
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	152668000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-962851000
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-486050000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4398805000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	4459070000
CY2022Q2	us-gaap	Minority Interest MinorityInterest	42561000
CY2021Q2	us-gaap	Minority Interest MinorityInterest	6243000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4441366000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4465313000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5449694000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6025362000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	405326000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	309273000
CY2020	us-gaap	Gross Profit GrossProfit	96053000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	93789000
CY2022	us-gaap	Selling Expense SellingExpense	34926000
CY2021	us-gaap	Selling Expense SellingExpense	26576000
CY2020	us-gaap	Selling Expense SellingExpense	18975000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	115191000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	35221000
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	378241000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	50679000
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	16518000
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	3251000
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1834000
CY2022	tlry	Transaction Costs TransactionCosts	31739000
CY2021	tlry	Transaction Costs TransactionCosts	60361000
CY2020	tlry	Transaction Costs TransactionCosts	2465000
CY2022	us-gaap	Operating Expenses OperatingExpenses	727218000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-610401000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	197671000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-184838000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3060000
CY2020	tlry	Shares Issued Value For Exercise Of Warrants SharesIssuedValueForExerciseOfWarrants	858000
CY2022	tlry	Stock Issued During Period Value Legal Settlement StockIssuedDuringPeriodValueLegalSettlement	22170000
CY2022	tlry	Stock Issued During Period Value Purchase Of Capital And Intangible Assets StockIssuedDuringPeriodValuePurchaseOfCapitalAndIntangibleAssets	12146000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18079000
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	6610000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8972000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8352000
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000
CY2021	us-gaap	Profit Loss ProfitLoss	-336014000
CY2020	us-gaap	Profit Loss ProfitLoss	-100833000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-476801000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-367421000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	42669000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31407000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1707000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-125306000
CY2022	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-71428000
CY2021	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-3824000
CY2020	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-5476000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-196734000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	152825000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6334000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-630866000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-183189000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-107167000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-108874000
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	19367000
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	31407000
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1707000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	481219130
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	269549852
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	216158217
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	481219130
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	269549852
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	216158217
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.90
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.25
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.90
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.25
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1234082000
CY2020	tlry	Share Issuance Value For Debt Settlement ShareIssuanceValueForDebtSettlement	58234000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-107167000
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1274931000
CY2021	tlry	Stock Issued During Period Value Legal Settlement StockIssuedDuringPeriodValueLegalSettlement	10454000
CY2021	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	103537000
CY2021	tlry	Stock Issued During Period Values Contract Settlement StockIssuedDuringPeriodValuesContractSettlement	-18895000
CY2021	tlry	Stock Issued During Period Value Arrangement StockIssuedDuringPeriodValueArrangement	3204906000
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	144000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19391000
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	11855000
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-183189000
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4465313000
CY2022	tlry	Stock Issued During Period Value Equity Financing StockIssuedDuringPeriodValueEquityFinancing	262509000
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4441366000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-100627000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	14816000
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5403000
CY2022	tlry	Cash Paid To Net Settle Employee Withholding Taxes Effectively Buying Back Shares CashPaidToNetSettleEmployeeWithholdingTaxesEffectivelyBuyingBackShares	-8686000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	34064000
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	38874000
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	98786000
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	12205000
CY2022	tlry	Adjustments To Additional Paid In Capital Share Based Compensation AdjustmentsToAdditionalPaidInCapitalShareBasedCompensation	35994000
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-630866000
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	6608000
CY2020	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1411000
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	2419000
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	6772000
CY2021	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	5752000
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	262509000
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000
CY2021	us-gaap	Profit Loss ProfitLoss	-336014000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-24873000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-49342000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	451000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	154592000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67832000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	35669000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	682000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1523000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8075000
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	67000000
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	19919000
CY2022	tlry	Impairment Impairment	378240000
CY2020	tlry	Impairment Impairment	50679000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	9647000
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3025000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9608000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	35994000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	17351000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	18079000
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-4914000
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1624000
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-24295000
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	227583000
CY2021	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-169537000
CY2020	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	53611000
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-44650000
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	59917000
CY2022	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	91771000
CY2021	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	70854000
CY2020	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	78832000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177262000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44717000
CY2020	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	19396000
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	451000
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	8430000
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	19570000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-326000
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-66608000
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	25902000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21533000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	46105000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-69946000
CY2021	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	144000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	102550000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	74395000
CY2022	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	-3283000
CY2020	tlry	Proceeds From Payment For Warrants And Options Exercised ProceedsFromPaymentForWarrantsAndOptionsExercised	3918000
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	88026000
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	812000
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	102798000
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60944000
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40254000
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	64559000
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	8114000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4672000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1058000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	126000
CY2022	tlry	Increase In Bank Indebtedness IncreaseInBankIndebtedness	-9406000
CY2021	tlry	Increase In Bank Indebtedness IncreaseInBankIndebtedness	-8328000
CY2020	tlry	Increase In Bank Indebtedness IncreaseInBankIndebtedness	-401000
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	7484000
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	23895000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128196000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	124308000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	130606000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1958000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2124000
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6572000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-72557000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	127820000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-46539000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	488466000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	360646000
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	407185000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	415909000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	488466000
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	360646000
CY2022	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:8pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td> <td valign="top"> <p style="margin-top:8pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Basis of preparation</p></td></tr></table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The policies applied in these consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”).</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the <span style="color:#000000;">determination</span> that Aphria was the accounting acquirer in the Arrangement, Aphria’s historical financial statements became the historical financial statements of the Company. The acquired assets and liabilities of Tilray are included in the Company’s consolidated balance sheets as of April 30, 2021 and the results of its operations and cash flows are included in the Company’s consolidated statement of loss and comprehensive loss and cash flows for periods beginning after April 30, 2021. <span style="color:#000000;">In conjunction with the reverse acquisition, the Company elected to adopt Aphria’s fiscal year end of June 1 to May 31</span>. Accordingly, comparisons between the Company's results for the year ended May 31, 2022 and prior periods may not be meaningful, as the reported results do not include the operations of legacy-Tilray and its subsidiaries on and prior to April 30, 2021.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements have been prepared on the going concern basis <span style="Background-color:#FFFFFF;color:#000000;">which assumes that the Company </span>will continue in operation for the foreseeable future and, accordingly, will be able to realize its assets and discharge its liabilities in the normal course of operations as they come due, under the historical cost convention except for certain financial instruments that are measured at fair value, as detailed in the Company’s accounting policies. For the years ended May 31, 2022, 2021 and 2020, the Company reported a consolidated net loss of $(434,132), $(336,014) and $(100,833), respectively. For the years ended May 31, 2022, </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Company had cash flows used in operating activities of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(177,262)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44,717)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100,627)</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, respectively. As of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">May 31, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Company had working capital of </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>523,161<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</span>482,368<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> respectively</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> Current </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">management</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> forecasts and related assumptions support the view that the Company can adequately manage the operational needs of the business with the current cash on hand for the next twelve months from the date of issuance of these financial statements.</span></p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:2.88%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Foreign currency</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements are presented in U.S. dollars (“USD”), which is the Company’s reporting currency; <span style="color:#000000;">however</span>, the functional currency of the entities in these financial statements are their respective local currencies, including Canadian dollar, USD, Euro, Australian dollar, and Great Britain pound.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign currency transactions are remeasured to the respective functional currencies of the Company’s entities at the exchange rates in effect on the date of the transactions. Monetary assets and liabilities denominated in foreign currencies are remeasured to the functional currency at the foreign exchange rate applicable at the statement of financial position date. Non-monetary items <span style="color:#000000;">carried at historical cost denominated in foreign currencies are remeasured to the functional currency at the date of the transactions. Non-monetary items carried at fair value denominated in foreign currencies are remeasured to the functional currency at the date when the fair value was determined. Realized and unrealized exchange gains and losses are recognized through profit and loss.</span></p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;letter-spacing:-0.2pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On consolidation, the assets and liabilities of foreign operations reported in their functional currencies are translated into USD, the Group’s presentation currency, at period-end exchange rates. Income and expenses, and cash flows of foreign operations are translated into USD using average exchange rates. Exchange differences resulting from translating foreign operations are recognized in other comprehensive income (loss) and accumulated in equity. </p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:2.88%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Basis of consolidation </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The consolidated financial statements of the Company, include the accounts of the company, its wholly-owned subsidiaries and majority owned subsidiaries (see Note 21). All significant intercompany transactions are eliminated. </p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:2.88%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Equity method investments</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 323, <span style="font-style:italic;">Investments – Equity Method and Joint Ventures, </span>investments in entities over which the Company does not have a controlling financial interest but has significant influence are accounted for using the equity method, with the Company’s share of earnings or losses reported in earnings or losses from equity method investments on the statements of net loss and comprehensive loss. Equity method investments are recognized initially at cost, which includes transaction costs. After initial recognition, the consolidated financial statements include the Company’s share of undistributed earnings or losses, and impairment, if any, until the date on which significant influence ceases.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company’s share of losses in an equity investment equals or exceeds its interest in the entity, including any net advances, the group does not recognize further losses, unless it has guaranteed obligations of the investee or is otherwise committed to provide further financial support for the investee.</p>
CY2022	us-gaap	Profit Loss ProfitLoss	-434132000
CY2022Q2	tlry	Working Capital WorkingCapital	523161000
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3613000
CY2021Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	651000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11329000
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	18465000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2021Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	35481000
CY2022Q2	tlry	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	18032000
CY2021Q2	tlry	Operating And Financing Lease Liability OperatingAndFinancingLeaseLiability	58210000
CY2022Q2	us-gaap	Inventory Net InventoryNet	245529000
CY2021Q2	us-gaap	Inventory Net InventoryNet	256429000
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	754740000
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	727574000
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	167241000
CY2021Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	76876000
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	587499000
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	650698000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12996000
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18267000
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	34726000
CY2022Q2	tlry	Operating And Finance Lease Right Of Use Assets OperatingAndFinanceLeaseRightOfUseAssets	12996000
CY2021Q2	tlry	Operating And Finance Lease Right Of Use Assets OperatingAndFinanceLeaseRightOfUseAssets	52993000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6703000
CY2021	tlry	Finance Lease Cost Amortization Of Right Of Use Assets FinanceLeaseCostAmortizationOfRightOfUseAssets	806000
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	765000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	3499000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1374000
CY2022	us-gaap	Lease Cost LeaseCost	3499000
CY2021	us-gaap	Lease Cost LeaseCost	2945000
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0
CY2022	us-gaap	Sublease Income SubleaseIncome	0
CY2021Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1605918000
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2474000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4087000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1466000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	736000
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	774000
CY2022	tlry	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	572000
CY2021	tlry	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	231000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4115000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3377000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2782000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3047000
CY2022Q2	tlry	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	6891000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	20212000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2180000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	18032000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1642843000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1673450000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	154124000
CY2021Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	52192000
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	210844000
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	15340000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1277875000
CY2020	tlry	Impairment Charges Offset In Net Liabilities ImpairmentChargesOffsetInNetLiabilities	4065000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	67591000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	60947000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	59912000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	59912000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	59912000
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	611190000
CY2022Q2	tlry	Finite Lived Intangible Assets Amortization Expense Net FiniteLivedIntangibleAssetsAmortizationExpenseNet	919464000
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	39640000
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	63713000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	223931000
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	41195000
CY2022Q2	us-gaap	Goodwill Goodwill	2641305000
CY2021Q2	us-gaap	Goodwill Goodwill	2832794000
CY2022	tlry	Goodwill Impairment Discount Rate GoodwillImpairmentDiscountRate	0.1121
CY2022	tlry	Goodwill Impairment Terminal Growth Rate GoodwillImpairmentTerminalGrowthRate	0.05
CY2022	tlry	Goodwill Impairment Average Revenue Growth Rate GoodwillImpairmentAverageRevenueGrowthRate	0.46
CY2022	tlry	Additional Impairment From One Percentage Increase In Discount Rate AdditionalImpairmentFromOnePercentageIncreaseInDiscountRate	587000000
CY2022	tlry	Additional Impairment From One Percentage Decrease In Terminal Growth Rate AdditionalImpairmentFromOnePercentageDecreaseInTerminalGrowthRate	457000000
CY2022	tlry	Additional Impairment From Five Percentage Decrease In Average Revenue Growth Rate AdditionalImpairmentFromFivePercentageDecreaseInAverageRevenueGrowthRate	553000000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	50679000
CY2020	tlry	Impairment Charges Recorded In Capital Assets ImpairmentChargesRecordedInCapitalAssets	5229000
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	15340000
CY2020	tlry	Impairment Charges Offset In Nci Portion ImpairmentChargesOffsetInNCIPortion	7020000
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	19570000
CY2022	tlry	Unrealized Losses On Change In Fair Value Of Investments UnrealizedLossesOnChangeInFairValueOfInvestments	6731000
CY2021	tlry	Unrealized Losses On Change In Fair Value Of Investments UnrealizedLossesOnChangeInFairValueOfInvestments	1567000
CY2020	tlry	Unrealized Losses On Change In Fair Value Of Investments UnrealizedLossesOnChangeInFairValueOfInvestments	23057000
CY2022Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	4347000
CY2021Q2	us-gaap	Equity Method Investments Fair Value Disclosure EquityMethodInvestmentsFairValueDisclosure	12185000
CY2022Q2	tlry	Equity Investments Under Measurement Alternative EquityInvestmentsUnderMeasurementAlternative	5703000
CY2021Q2	tlry	Equity Investments Under Measurement Alternative EquityInvestmentsUnderMeasurementAlternative	5500000
CY2022Q2	us-gaap	Other Investments OtherInvestments	10050000
CY2021Q2	us-gaap	Other Investments OtherInvestments	17685000
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	8430000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8352000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-344986000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-81772000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-323964000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-88930000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-440674000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-344986000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-109185000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	262000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23268000
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15227000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5294000
CY2022	tlry	Current Other Countries Foreign Tax Expense Benefit CurrentOtherCountriesForeignTaxExpenseBenefit	479000
CY2021	tlry	Current Other Countries Foreign Tax Expense Benefit CurrentOtherCountriesForeignTaxExpenseBenefit	697000
CY2020	tlry	Current Other Countries Foreign Tax Expense Benefit CurrentOtherCountriesForeignTaxExpenseBenefit	375000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24009000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15924000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5669000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	520000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1517000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-17154000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-30111000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9226000
CY2022	tlry	Deferred Other Countries Foreign Tax Expense Benefit DeferredOtherCountriesForeignTaxExpenseBenefit	-13917000
CY2021	tlry	Deferred Other Countries Foreign Tax Expense Benefit DeferredOtherCountriesForeignTaxExpenseBenefit	3698000
CY2020	tlry	Deferred Other Countries Foreign Tax Expense Benefit DeferredOtherCountriesForeignTaxExpenseBenefit	-4795000
CY2022	tlry	Deferred Income Tax Expense Recoveries DeferredIncomeTaxExpenseRecoveries	-30551000
CY2021	tlry	Deferred Income Tax Expense Recoveries DeferredIncomeTaxExpenseRecoveries	-24896000
CY2020	tlry	Deferred Income Tax Expense Recoveries DeferredIncomeTaxExpenseRecoveries	-14021000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8972000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-109185000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	92542000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	72408000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	22929000
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	81316000
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-19016000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-6310000
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	14941000
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	1011000
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies Foreign IncomeTaxReconciliationTaxContingenciesForeign	-63000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	6404000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-1347000
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	354071000
CY2022	tlry	Income Tax Reconciliation Non Deductible Taxable Losses IncomeTaxReconciliationNonDeductibleTaxableLosses	748000
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	265940000
CY2020Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	69580000
CY2022Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	8378000
CY2021Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	4977000
CY2020Q2	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	4056000
CY2021	tlry	Income Tax Reconciliation Non Deductible Taxable Losses IncomeTaxReconciliationNonDeductibleTaxableLosses	45230000
CY2020	tlry	Income Tax Reconciliation Non Deductible Taxable Losses IncomeTaxReconciliationNonDeductibleTaxableLosses	13305000
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	135000
CY2022	tlry	Income Tax Reconciliation Change In Fair Value Of Warrant Liability IncomeTaxReconciliationChangeInFairValueOfWarrantLiability	-13359000
CY2021	tlry	Income Tax Reconciliation Change In Fair Value Of Warrant Liability IncomeTaxReconciliationChangeInFairValueOfWarrantLiability	-259000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	994000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	2902000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	4105000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17255000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	46007000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1066000
CY2021	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	755000
CY2022	tlry	Income Tax Reconciliation Impact On Convertible Debenture And Other Differences IncomeTaxReconciliationImpactOnConvertibleDebentureAndOtherDifferences	22299000
CY2021	tlry	Income Tax Reconciliation Effect Of Transaction IncomeTaxReconciliationEffectOfTransaction	-10472000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6542000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8972000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8352000
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	132293000
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	152382000
CY2020Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	20512000
CY2022Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	38087000
CY2021Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1350000
CY2020Q2	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1854000
CY2022Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	150543000
CY2021Q2	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	86541000
CY2022Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	20592000
CY2021Q2	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	17107000
CY2022Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	7165000
CY2021Q2	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	9491000
CY2021Q2	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	34108000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1638000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	4237000
CY2020Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	5022000
CY2022Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	21590000
CY2021Q2	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	526000
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	44393000
CY2021Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	26434000
CY2020Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1704000
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	509775000
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	397297000
CY2020Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	38129000
CY2020Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4583000
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	155704000
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	131357000
CY2020Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	33546000
CY2022Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	38387000
CY2021Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	15997000
CY2020Q2	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	8356000
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	305577000
CY2021Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	376228000
CY2022	tlry	Adjustable Taxable Income Deductible Net Interest Percentage AdjustableTaxableIncomeDeductibleNetInterestPercentage	0.50
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	352342000
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	397202000
CY2020Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	81992000
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	196638000
CY2021Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	265845000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	743333333
CY2020Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	48446000
CY2020Q1	tlry	Adjustable Taxable Income Deductible Net Interest Percentage AdjustableTaxableIncomeDeductibleNetInterestPercentage	0.30
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	446440641
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	6150000
CY2021Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	14764000
CY2017Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022Q2	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	449500000
CY2022	tlry	Operating Loss Carryforward Expiration Period OperatingLossCarryforwardExpirationPeriod	P20Y
CY2022	tlry	Operating Loss Carry Forwards Expiration Year OperatingLossCarryForwardsExpirationYear	2028
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2021Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022	tlry	Operating Line Of Credit OperatingLineOfCredit	1000
CY2022Q2	us-gaap	Line Of Credit LineOfCredit	0
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	68604000
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	57706000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57497000
CY2021Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	112594000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17736000
CY2021Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19390000
CY2021Q2	us-gaap	Interest Payable Current InterestPayableCurrent	148000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-173432000
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20764000
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	446440641
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	446440641
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	51741710
CY2022	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	267762000
CY2022Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	672000
CY2021Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	8211000
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	157431000
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	212813000
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	187152000
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	206169000
CY2022Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1450000
CY2021Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2061000
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	185702000
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	204108000
CY2022Q2	tlry	Principal Portion Included In Current Liabilities PrincipalPortionIncludedInCurrentLiabilities	67823000
CY2021Q2	tlry	Principal Portion Included In Current Liabilities PrincipalPortionIncludedInCurrentLiabilities	36622000
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	117879000
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	167486000
CY2022	tlry	Minimum Balance Maintained To Remove Financial Covenants MinimumBalanceMaintainedToRemoveFinancialCovenants	7083000
CY2022	tlry	Minimum Balance Maintained To Remove Financial Covenants MinimumBalanceMaintainedToRemoveFinancialCovenants	5596000
CY2022	tlry	Minimum Balance Maintained In Cash Operating Accounts MinimumBalanceMaintainedInCashOperatingAccounts	1350000
CY2022	tlry	Minimum Balance Maintained In Cash Operating Accounts MinimumBalanceMaintainedInCashOperatingAccounts	1067000
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	401949000
CY2021Q2	us-gaap	Convertible Debt ConvertibleDebt	667624000
CY2022	tlry	Class Of Warrant Expired ClassOfWarrantExpired	5994651
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	6209000
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.95
CY2022	tlry	Class Of Warrant Or Right Expiration Date ClassOfWarrantOrRightExpirationDate	2025-03-17
CY2022Q2	tlry	Reduction In Exercise Price Of Warrants ReductionInExercisePriceOfWarrants	4.30
CY2022	tlry	Percentage Of Daily Cash Penalty PercentageOfDailyCashPenalty	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	990000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	532674887
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	532674887
CY2022	tlry	Agents Commissions And Fees AgentsCommissionsAndFees	5253000
CY2022	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	262509000
CY2022	tlry	Stock Issued During Period Shares Legal Settlement StockIssuedDuringPeriodSharesLegalSettlement	2959386
CY2021Q4	tlry	Stock Issued During Period Shares Purchase Of Capital And Intangible Assets StockIssuedDuringPeriodSharesPurchaseOfCapitalAndIntangibleAssets	1289628
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	5208386
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35994000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17351000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18079000
CY2019Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	900000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6334000
CY2020Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5434000
CY2022	us-gaap	Professional Fees ProfessionalFees	13047000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	628372000
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	513085000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	389903000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	309273000
CY2021	tlry	Settlement Of Convertible Notes Receivable SettlementOfConvertibleNotesReceivable	5277000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	152825000
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	152668000
CY2020	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	405326000
CY2020	us-gaap	General Insurance Expense GeneralInsuranceExpense	9370000
CY2020	tlry	Distribution Cost DistributionCost	240722000
CY2022	tlry	Wellness Cost WellnessCost	41457000
CY2021	tlry	Wellness Cost WellnessCost	4233000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	511555000
CY2022	tlry	Cannabi Costs CannabiCosts	194834000
CY2021	tlry	Cannabi Costs CannabiCosts	130511000
CY2020	tlry	Cannabi Costs CannabiCosts	68551000
CY2022	tlry	Beverage Alcohol Cost BeverageAlcoholCost	32033000
CY2021	tlry	Beverage Alcohol Cost BeverageAlcoholCost	12687000
CY2022	tlry	Distribution Cost DistributionCost	243231000
CY2021	tlry	Distribution Cost DistributionCost	242472000
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	14128000
CY2021	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	8645000
CY2020	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	6777000
CY2022	tlry	Office And General Expenses OfficeAndGeneralExpenses	27153000
CY2021	tlry	Office And General Expenses OfficeAndGeneralExpenses	19503000
CY2020	tlry	Office And General Expenses OfficeAndGeneralExpenses	12351000
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	51693000
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	37126000
CY2020	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	28252000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	35994000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17351000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18079000
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	17536000
CY2021	us-gaap	General Insurance Expense GeneralInsuranceExpense	12257000
CY2020	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-24295000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5208000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9080000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21266000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	197671000
CY2021	us-gaap	Professional Fees ProfessionalFees	11779000
CY2020	us-gaap	Professional Fees ProfessionalFees	14190000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	682000
CY2022	us-gaap	Proceeds From Insurance Premiums Collected ProceedsFromInsurancePremiumsCollected	4032000
CY2022	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	4203000
CY2021	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	2711000
CY2020	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	2798000
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	3761000
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	2203000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	1972000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162801000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	111575000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	93789000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	11736000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	2926000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	6273000
CY2022	us-gaap	Interest Expense InterestExpense	39680000
CY2021	us-gaap	Interest Expense InterestExpense	30903000
CY2020	us-gaap	Interest Expense InterestExpense	25644000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27944000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-27977000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-19371000
CY2022	tlry	Fair Value Adjustment Of Convertible Debenture FairValueAdjustmentOfConvertibleDebenture	-163670000
CY2021	tlry	Fair Value Adjustment Of Convertible Debenture FairValueAdjustmentOfConvertibleDebenture	170453000
CY2020	tlry	Fair Value Adjustment Of Convertible Debenture FairValueAdjustmentOfConvertibleDebenture	-53611000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-63913000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1234000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-28383000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-22347000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6145000
CY2022	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-6737000
CY2021	tlry	Gain Loss On Long Term Investments GainLossOnLongTermInvestments	-2352000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5842000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-184838000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14195000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-23512000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-25593000
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	4472000
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-6772000
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-10899000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45749000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-55205000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-89660000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-44652000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14635000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	47320000
CY2022	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	91771000
CY2021	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	70854000
CY2020	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	78832000
CY2022Q2	us-gaap	Other Commitment OtherCommitment	709645000
CY2022Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	118981000
CY2022Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	293540000
CY2022Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	264689000
CY2022Q2	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	4092000
CY2022Q2	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	4380000
CY2022Q2	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	23963000
CY2022Q2	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	17839000
CY2021Q2	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	20358000
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	5404000
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4571000
CY2022	tlry	Hypothetical Decrease In Fair Value Of Investments HypotheticalDecreaseInFairValueOfInvestments	0.10
CY2022	tlry	Estimated Decrease In Fair Values Of Investments Upon Hypothetical Decrease In Prices EstimatedDecreaseInFairValuesOfInvestmentsUponHypotheticalDecreaseInPrices	12123000
CY2022	tlry	Hypothetical Increase In Common Stock HypotheticalIncreaseInCommonStock	0.10
CY2022	tlry	Estimated Increase In Fair Values Of Warrant Liability On Hypothetical Increase In Prices EstimatedIncreaseInFairValuesOfWarrantLiabilityOnHypotheticalIncreaseInPrices	1787000
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	628372000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	513085000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	405326000
CY2022Q2	tlry	Capital Assets CapitalAssets	587499000
CY2021Q2	tlry	Capital Assets CapitalAssets	650698000
CY2022	tlry	Number Of Major Customers NumberOfMajorCustomers	0
CY2021	tlry	Number Of Major Customers NumberOfMajorCustomers	0
CY2020	tlry	Number Of Major Customers NumberOfMajorCustomers	0
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Toronto, Canada

Files In Submission

Name	View Source	Status
0001564590-22-026894-index-headers.html	Edgar Link	pending
0001564590-22-026894-index.html	Edgar Link	pending
0001564590-22-026894.txt	Edgar Link	pending
0001564590-22-026894-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
glxlxgg1wl5o000001.jpg	Edgar Link	pending
gq2w5mos2thj000001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tlry-10k_20220531.htm	Edgar Link	pending
tlry-10k_20220531_htm.xml	Edgar Link	completed
tlry-20220531.xsd	Edgar Link	pending
tlry-20220531_cal.xml	Edgar Link	unprocessable
tlry-20220531_def.xml	Edgar Link	unprocessable
tlry-20220531_lab.xml	Edgar Link	unprocessable
tlry-20220531_pre.xml	Edgar Link	unprocessable
tlry-ex1014_195.htm	Edgar Link	pending
tlry-ex211_12.htm	Edgar Link	pending
tlry-ex231_7.htm	Edgar Link	pending
tlry-ex311_9.htm	Edgar Link	pending
tlry-ex312_13.htm	Edgar Link	pending
tlry-ex321_6.htm	Edgar Link	pending
tlry-ex44_197.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TLRY
Tilray Brands, Inc. Stock $tlry

2022 Q3 Form 10-K Financial Statement

#000156459022026894 Filed on July 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLRY Tilray Brands, Inc. Stock $tlry

2022 Q3 Form 10-K Financial Statement

#000156459022026894 Filed on July 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TLRY
Tilray Brands, Inc. Stock $tlry